Trials / Completed
CompletedNCT05525195
Influence of Preop Fibrinogen on Blood in Pediatric Cardiac Surgery
Influence of Preoperative Fibrinogen Levels on Blood Loss and Transfusions in Pediatric Cardiac Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 932 (actual)
- Sponsor
- Brugmann University Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Fibrinogen plays an important role in the coagulation cascade. Low levels of preoperative fibrinogen have been associated in adults with higher blood and transfusion requirements during surgery. Guidelines from the European Society of Anesthesiology and Intensive Care recommends fibrinogen substitution based on viscoelastic tests in adult cardiac surgery. Cardiopulmonary bypass results in a profound hemodilution and dilution of all coagulation factors. This is especially true in children where the priming volume of the cardiopulmonary bypass circuit is much higher compared to the patient's weight than in adults. Cardiopulmonary bypass generates high levels of tissue plasminogen activator resulting in a hyperfibrinolysis, further lowering fibrinogen levels. The aim of this retrospective study is to explore a possible relationship between preoperative fibrinogen levels and perioperative blood loss, as well as transfusion requirements in children undergoing cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Congenital cardiac surgery | All children who underwent congenital cardiac surgery with cardiopulmonary bypass between 2008 and 2018 |
Timeline
- Start date
- 2022-09-17
- Primary completion
- 2023-01-25
- Completion
- 2023-02-10
- First posted
- 2022-09-01
- Last updated
- 2023-07-27
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05525195. Inclusion in this directory is not an endorsement.